These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Optic disk melanocytoma associated with polypoidal choroidal vasculopathy lesions, after combination treatment of photodynamic therapy and intavitreal aflibercept (Eylea), a case report. Rouvas A; Gouliopoulos NS; Moschos MM; Theodossiadis P BMC Ophthalmol; 2018 Oct; 18(1):267. PubMed ID: 30309335 [TBL] [Abstract][Full Text] [Related]
15. Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes - A multicenter retrospective study. Chakraborty D; Maiti A; Sengupta S; Mondal S; Nandi K; Chakraborty S Indian J Ophthalmol; 2022 Apr; 70(4):1295-1299. PubMed ID: 35326038 [TBL] [Abstract][Full Text] [Related]
16. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results. Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps. Lee SE; Jang JW; Kang SW; Park KH; Lee DW; Kim JH; Bae K Sci Rep; 2019 Feb; 9(1):1487. PubMed ID: 30728380 [TBL] [Abstract][Full Text] [Related]
18. Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy. Morimoto M; Matsumoto H; Mimura K; Akiyama H Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1891-1897. PubMed ID: 28669041 [TBL] [Abstract][Full Text] [Related]
19. Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy. Kim H; Lee SC; Kwon KY; Lee JH; Koh HJ; Byeon SH; Kim SS; Kim M; Lee CS Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1497-1503. PubMed ID: 26626772 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal antivascular endothelial growth factor for polypoidal choroidal vasculopathy. Komuku Y; Iwahashi C; Gomi F Jpn J Ophthalmol; 2020 May; 64(3):265-270. PubMed ID: 32206935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]